Efficacy of Topiramate for Weight Loss in Subjects With Metabolic Syndrome

PHASE3SuspendedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

March 31, 2005

Study Completion Date

November 30, 2007

Conditions
Metabolic Syndrome XDiabetes Mellitus, Type 2
Interventions
DRUG

topiramate

Trial Locations (5)

44307

Akron General Medical Center, Akron

44501

Forum Health/Northside Medical Center, Youngstown

St. Elizabeth Health Center, Youngstown

44708

Mercy Medical Center, Canton

44710

Aultman Hospital, Canton

Sponsors
All Listed Sponsors
collaborator

Cleveland Clinic Akron General

OTHER

collaborator

Forum Health

INDUSTRY

collaborator

Aultman Health Foundation

OTHER

collaborator

St. Elizabeth Health Center

UNKNOWN

collaborator

Mercy Medical Center

OTHER

lead

Northeastern Ohio Universities College of Medicine

OTHER